Table 3. Freedom from reoperation for tricuspid valve replacement stratified by patients with intravenous drug use associated infective tricuspid valve endocarditis who underwent tricuspid valvectomy as compared to tricuspid valve replacement for the index procedure.

Time from operation	Valve replacement					Valvectomy					Overall
	Pooled value [95% CI]	No. of studies	No. of patients	I2 (%)		Pooled value [95% CI]	No. of studies	No. of patients	I2 (%)		P value	I2 (%)
30 days	88 [77–95]	8	48/51	0		96 [82–99]	3	40/40	0		0.23	0
3 months	89 [73–96]	7	27/27	0		96 [82–99]	3	40/40	0		0.30	0
6 months	89 [73–96]	7	27/27	0		97 [79–100]	2	32/32	0		0.30	0
9 months	89 [73–96]	7	27/27	0		97 [79–100]	2	32/32	0		0.30	0
1 year	89 [73–96]	7	27/27	0		46 [8–90]	3	18/40	72*		0.06	62
All	86 [73–93]	10	47/51	0		44 [10–85]	3	17/40	70*		0.06	36

*, heterogeneity P<0.05 (significant data heterogeneity present).